Edyta Szałek

Edyta Szałek

Auto-generated profile, based on publicly available information

Edyta Szałek

Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, Poznań, Poland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Miłosz MiedziaszczykMiłosz Miedziaszczyk
Miłosz Miedziaszczyk
PCPatrycja Ciabach
Patrycja Ciabach
ESEdyta Szałek
Edyta Szałek
Bariatric surgery, which is an effective treatment for obesity, and gastrectomy, which is the primary treatment method for gastric cancer, alter the anatomy and physiology of the digestive system. Weight loss and changes in the gastrointestinal tract may affect the pharmacokinetic parameters of oral medications. Both bariatric and cancer patients use drugs chronically or temporarily. It is important to know how surgery affects their pharmacokinetics to ensure an effective and safe therapy. The Cochrane, PubMed, and Scopus databases were searched independently by two authors. The search strategy included controlled vocabulary and keywords. Studies show that bariatric surgery and gastrectomy most often reduce the time to maximum plasma concentration (tmax) and decrease the maximum plasma concentration (Cmax) in comparison with the values of these parameters measured in healthy volunteers. Vitamin and mineral deficiencies are also observed. The effect depends on the type of surgery and the properties of the drug. It is recommended to use the drugs that have been tested on these groups of patients as it is possible to monitor them.

8 June 2019 in Investigational New Drugs
Verified
Journal Article
Open access
PDF file
AKAgnieszka Karbownik
Agnieszka Karbownik
KSKatarzyna Sobańska
Katarzyna Sobańska
WPWłodzimierz Płotek
Włodzimierz Płotek
TGTomasz Grabowski
Tomasz Grabowski
AKAgnieszka Klupczynska-Gabryszak
Agnieszka Klupczynska-Gabryszak
ESEdyta Szałek
Edyta Szałek
Summary: Background Lapatinib is a small-molecule tyrosine kinase inhibitor of human epidermal receptor 2 (HER2) and EGFR that has currently been approved for the treatment of HER2-positive advanced and metastatic breast cancer (BC). The ATP-binding cassette (ABC) family of transporters includes P-glycoprotein (P-gp; ABCB1) and breast cancer resistance protein (BCRP; ABCG2), which substantially restrict the penetration of drugs, including chemotherapeutics, through the blood-brain barrier and blood-cerebrospinal fluid barrier. The aim of this study was to investigate the effects of elacridar, an ABCB1 and ABCG2 inhibitor, on the brain and cerebrospinal fluid uptake of lapatinib. Methods Rats were divided into two groups: one group received 5 mg/kg elacridar and 100 mg/kg lapatinib (an experimental group), and the other group received 100 mg/kg lapatinib (a control group). Lapatinib concentrations in the blood plasma (BP), cerebrospinal fluid (CSF) and brain tissue (BT) were measured by liquid chromatography coupled with tandem mass spectrometry. Results Elacridar significantly increased lapatinib penetration into the CSF and BT (Cmax increase of 136.4% and 54.7% and AUC0-∞ increase of 53.7% and 86.5%, respectively). The Cmax of lapatinib in BP was similar in both experimental groups (3057.5 vs. 3257.5 ng/mL, respectively). Conclusion This study showed that elacridar influenced the pharmacokinetics of lapatinib. The inhibition of ABCB1 and ABCG2 transporters by elacridar substantially enhanced the penetration of lapatinib into the CSF and BT. The blocking of protein transporters could become indispensable in the treatment of patients with breast cancer and brain metastases.

20 July 2016 in Journal of Analytical Chemistry
Verified
Journal Article
Closed access
ACA. Czyrski
A. Czyrski
ESE. Szałek
E. Szałek

2 January 2017 in Journal of Liquid Chromatography & Related Technologies
Verified
Journal Article
Closed access
Andrzej CzyrskiAndrzej Czyrski
Andrzej Czyrski
ASAgnieszka Sokół
Agnieszka Sokół
ESEdyta Szałek
Edyta Szałek
Moxifloxacin is a representative of the fourth generation of fluoroquinolones. It possesses bacteriostatic activity against Gram-positive and Gram-negative bacteria. A simple and fast high performance liquid chromatography-ultraviolet detection (HPLC-UV) method was developed for moxifloxacin analysis. The separation was performed on C18 column. The mobile phase was a mixture of acetonitrile and 0.4% triethylamine solution. The regression curve was linear over the range 0.2–10.0 µg/mL. The validation parameters obey the European Medicine Agency limits. The in vivo study confirmed the practical application of the method. GRAPHICAL ABSTRACT

4 September 2013 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
HTHanna Tomczak
Hanna Tomczak
ESEdyta Szałek
Edyta Szałek
WBWioleta Błażejewska
Wioleta Błażejewska
KMKatarzyna Myczko
Katarzyna Myczko
AHAnna Horla
Anna Horla
EGEdmund Grześkowiak
Edmund Grześkowiak
Purpose: The aim of the study was a comparison of the MIC (minimal inhibitory concentration) evaluated in the automatic system Vitek 2 and the real MIC of vancomycin by the Etest method for S. aureus strains isolated from clinical materials. Material and Methods: Over a twelve-month study period we compared the results obtained with two commercial methods - the automatic system VITEK 2 and the real MIC by Etest - for 359 strains of S. aureus isolated from clinical materials. Results: Most of the strains of S. aureus were cultured from wounds (84), the ear (60) and nose (42). MSSA (methicillin-sensitive Staphylococcus aureus) was isolated in 342 cases and MRSA (methicillin-resistant Staphylococcus aureus) in 17 cases. The test with the Vitek automatic method showed that vancomycin had MIC values of <= 1.0 mu g/ml in more than 96% and 2.0 mu g/ml in over 3% of cases. Using the Etest technique MIC <= 1.0 mu g/ml was obtained in only 16.4% of cases and values of > 1.0 mu g/ml in 83.6% of cases. Discussion: In view of such big differences between the MIC values obtained with the two methods the authors suggest that the Etest method of assaying the real MIC is more useful than the automatic method.

1 June 2015 in Pharmacological Reports
Verified
Journal Article
Closed access
Andrzej CzyrskiAndrzej Czyrski
Andrzej Czyrski
KKKatarzyna Kondys
Katarzyna Kondys
ESEdyta Szałek
Edyta Szałek
AKAgnieszka Karbownik
Agnieszka Karbownik
EGEdmund Grześkowiak
Edmund Grześkowiak